To predict the efficacy of Dadimadi Ghruta as an add on therapy in chemotherapy induced anemia (low Hb levels)
Phase 1
- Conditions
- Health Condition 1: D638- Anemia in other chronic diseases classified elsewhere
- Registration Number
- CTRI/2022/03/040862
- Lead Sponsor
- Dr Komal Shriram Indulkar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Post Chemotherapy patients on hematinic for one month without significant change in hemoglobin level
hemoglobin in female less than 12 gm/dl
hemoglobin in male less than 13.5 gm/dl
Exclusion Criteria
Patients contra indicated for snehapana
Patients having thalassemia, sickle cell anemia and leukemia
Patients with low hemoglobin levels before chemotherapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Dadimadi Ghruta is effective in management of Chemotherapy induced Anemia.(to check increase in Haemoglobin levels in chemotherapy induced Anemia patients.)Timepoint: 30 days study with follow up on 15th and 30th day.
- Secondary Outcome Measures
Name Time Method positive change in quality lifeTimepoint: positive lifestyle changes